Effect of cardiopulmonary bypass on neutrophil activity in pediatric open-heart surgery

Archivum Immunologiae et Therapiae Experimentalis

Volumn 53, Issue 3, 2005, Pages 272-277

  Paśnik, Jarosław ^a   Siniewicz, Krzysztof ^a   Moll, Jadwiga Anna ^b   Moll, Jacek ^b   Baj, Zbigniew ^a   Sysa, Andrzej ^b   Zeman, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Polish Mothers Health Center Research Institute   (Poland)

Author keywords

Cardiopulmonary bypass; Neutrophil; Phagocytic activity; Systemic inflammatory response syndrome

Indexed keywords

CELL ADHESION MOLECULE; PROTEIN CD11B; UNCLASSIFIED DRUG;

AORTA STENOSIS; ARTICLE; CARDIOPULMONARY BYPASS; CELL ACTIVITY; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; FALLOT TETRALOGY; FEMALE; FLOW CYTOMETRY; GREAT VESSELS TRANSPOSITION; HUMAN; INFANT; MALE; NEUTROPHIL; OPEN HEART SURGERY; OPERATION DURATION; PHAGOCYTOSIS; PROTEIN EXPRESSION; PULMONARY ARTERY ATRESIA;

ANTIGENS, CD11B; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFLAMMATION; LEUKOCYTES; MALE; NEUTROPHIL ACTIVATION; NEUTROPHILS; PHAGOCYTOSIS; TIME FACTORS;

EID: 23044491480     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Alcaraz A. J., Sancho L., Manzano L., Esquivel F., Carrillo A., Prieto A., Bernstein E. D. and Alvarez-Mon M. (2002): Newborn patients exhibit an unusual pattern of interleukin 10 and interferon γ serum levels in response to cardiac surgery. J. Thorac. Cardiovasc. Surg., 123, 451-458.
2. Asimakopoulos G., Smith P. L., Ratnatunga C. P. and Taylor K. M. (1999): Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann. Thorac. Surg., 68, 1107-1115.
3. Baue A. E., Durham R. and Faist E. (1998): Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are winning the battle? Shock, 10, 79-89.
4. Burrows F. A., Steele R. W., Marmer D. J., van Devanter S. H. and Westerman G. R. (1987): Influence of operations with cardiopulmonary bypass on polymorphonuclear leukocyte function in infants. J. Thorac. Cardiovasc. Surg., 93, 253-260.
5. Checchia P. A., Backer C. L., Bronicki R. A., Baden H. P., Crawford S. E., Green T. P. and Mavroudis C. (2003): Dexamethasone reduces postoperative troponin levels in children undergoing cardiopulmonary bypass. Crit. Care Med., 31, 1742-1745.
6. Demircioglu F. F. (1989): Leukocyte phagocytosis during cardiopulmonary bypass in adolescents. Turk. J. Pediatr., 31, 127-135.
7. Haddad R., El-Hassan D., Araj A., Hallal A. and Abdelnoor A. M. (2001): Some inflammation-related parameters in patients following normo- and hypothermic cardio-pulmonary bypass. Immunopharmacol. Immunotoxicol., 23, 291-302.
8. Hamano K., Ito H., Katoh T., Fujimura Y., Tsuboi H. and Esato K. (1996): Granulocyte phagocytic function is impaired during cardiopulmonary bypass. Ann. Thorac. Surg., 62, 1820-1824.
9. Hambsch J., Osmancik P., Schneider P. and Tarnok A. (2002): Neutrophil adhesion molecule expression and serum concentration of soluble adhesion molecules during and after pediatric cardiovascular surgery with or without cardiopulmonary bypass. Anesthesiology, 96, 1078-1085.
10. Harlan J. M. and Winn R. K. (2002): Leukocyte-endothelial interactions: clinical trials of anti-adhesion therapy. Crit. Care Med., 30 (suppl.), 214-218.
11. Hayashi Y., Sawa Y., Fukuyama N., Miyamoto Y., Takahashi T., Nakazawa H. and Matsuda H. (2003): Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardium-derived nitric oxide and peroxynitrite production for patients undergoing prolonged aortic crossclamping for more than 120 minutes. J. Thorac. Cardiovasc. Surg., 126, 1813-1821.
12. Honore P. M., Jacquet L. M., Beale R. J., Renauld J. C., Valadi D., Noirhomme P. and Goenen M. (2001): Effects of normothermia versus hypothermia on extravascular lung water and serum cytokines during cardiopulmonary bypass: a randomized, controlled trial. Crit. Care Med., 29, 1903-1909.
13. Hill G. E. (1998): Cardiopulmonary bypass-induced inflammation: is it important? J. Cardiothorac. Vasc. Anesth., 12 (suppl. 1), 21-25.
14. Jensen R. H., Storgaard M., Vedelsdal R. and Obel N. (1995): Impaired neutrophil chemotaxis after cardiac surgery. Scand. J. Thorac. Cardiovasc. Surg., 29, 115-118.
15. Joashi U., Tibby S. M., Turner C., Mayer A., Austin C., Anderson D., Durward A. and Murdoch I. A. (2002): Soluble Fas may be a proinflammatory marker after cardiopulmonary bypass in children. J. Thorac. Cardiovasc. Surg., 123, 137-144.
16. Kawahito K., Kobayashi E., Ohmori M., Harada K., Kitoch Y., Fujimura A. and Fuse K. (2000): Enhanced responsiveness of circulatory neutrophils after cardiopulmonary bypass: increased aggregability and superoxide producing capacity. Artif. Organs, 24, 37-42.
17. Kress H. G., Gehrsitz P. and Elert O. (1987): Predictive value of skin testing, neutrophil migration and C-reactive protein for postoperative infections in cardiopulmonary bypass patients. Acta Anaesthesiol. Scand., 31, 397-404.
18. Oczenski W., Krenn H., Jilch R., Watzka H., Waldenberger F., Koller U., Schwarz S. and Fitzgerald R. D. (2003): HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery. Intensive Care Med., 29, 1253-1257.
19. Pasnik J., Tchórzewski H., Baj Z., Luciak M. and Tchorzewski M. (1999): Priming effect of met-enkephalin and β-endorphin on chemiluminescence, chemotaxis and CD11b molecule expression on human neutrophils in vitro. Immunol Lett., 67, 77-83.
20. Patrick D. A., Moore E. E., Fullerton D. A., Barnett C. C., Meldrum D. R. and Silliman C. C. (1999): Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late disability. J. Surg. Res., 86, 42-49.
21. Strohmeyer J. C., Blume C., Meisel C., Doecke W. D., Hummel M., Hoeflich C., Thiele K., Unbehaun A., Hetzer R. and Volk H. D. (2003): Standardized immune monitoring for the prediction of infections after cardiopulmonary bypass surgery in risk patients. Cytometry B Clin. Cytom., 53, 54-62.
22. Suzuki T., Fukuda T., Ito T., Inoue Y., Cho Y. and Kashima I. (2000): Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants. Ann. Thorac. Surg., 69, 602-606.
23. Tárnok A., Bocsi J., Pipek M., Osmancik P., Valet G., Schneider P. and Hambsch J. (2001): Preoperative prediction of postoperative edema and effusion in pediatric cardiac surgery by altered antigen expression patterns on granulocytes and monocytes. Cytometry, 46, 247-253.
24. Tárnok A., Bocsi J., Rössler H., Schlykow V., Schneider P. and Hambsch J. (2001): Low degree of activation of circulating neutrophils determined by flow cytometry during cardiac surgery with cardiopulmonary bypass. Cytometry, 46, 41-49.
25. Zahler S., Massoudy P., Hartl H., Hahnel C., Meisner H. and Becker B. F. (1999): Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass. Cardiovasc. Res., 41, 722-730.
26. Zilberstein G., Levy R., Rachinsky M., Fisher A., Greemberg L., Shapira Y., Appelbaum A. and Roytblat L. (2002): Ketamine attenuates neutrophil activation after cardiopulmonary bypass. Anesth. Analg., 95, 531-536.
27. Zimmerman J. J. and Ringer T. V. (1992): Inflammatory host response in sepsis. Crit. Care Clin., 8, 163-189.
28. Zimmermann A. K., Simon P., Seeburger J., Hoffmann J., Ziemer G., Aebert H. and Wendel H. P. (2003): Cytokine gene expression in monocytes of patients undergoing cardiopulmonary bypass surgery evaluated by real-time PCR. J. Cell Mol. Med., 7, 146-156.